Prostate Specific Antigen Levels of Individuals Living in Rural Areas
NCT06900348 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 308
Last updated 2025-03-30
Summary
It was planned in cross-sectional design in order to determine the specific prostate antigen level and some characteristics and the relationship evaluations and prostate specific antigen formation in individuals living in rural areas. It was planned to perform socio-demographic information formula, form including social information of health, prostate specific antigen test in the project data recording.
Conditions
- Prostate Carcinoma
Interventions
- DIAGNOSTIC_TEST
-
PSA-Activated PSA-PAH1
Intravenous blood sample
Sponsors & Collaborators
-
Suleyman Demirel University
lead OTHER
Eligibility
- Min Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-25
- Primary Completion
- 2025-07-30
- Completion
- 2025-08-30
More Related Trials
-
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
NCT04530552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prostate Cancer Study of Patient Experiences
NCT07096596 ·Status: NOT_YET_RECRUITING
-
PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
NCT00379561 ·Status: COMPLETED ·Phase: PHASE1
-
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.
NCT01123434 ·Status: COMPLETED
-
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
NCT03275181 ·Status: COMPLETED
-
PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
NCT00003871 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA
NCT01521949 ·Status: COMPLETED ·Phase: PHASE2
-
iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer
NCT07105020 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
NCT03290508 ·Status: TERMINATED
-
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
NCT02013180 ·Status: COMPLETED
-
Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021
NCT05382182 ·Status: UNKNOWN
-
Identification of Risk Allels for Prostate Cancer
NCT00323388 ·Status: WITHDRAWN
-
A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death
NCT03619980 ·Status: COMPLETED
-
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
NCT02499848 ·Status: COMPLETED ·Phase: PHASE2
-
Prostate Cancer Screening Among Men With High Risk Genetic Predisposition
NCT02053805 ·Status: UNKNOWN ·Phase: NA
-
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
NCT02452307 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters
NCT05399940 ·Status: COMPLETED
-
Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year
NCT00703768 ·Status: UNKNOWN
-
Early Stage Prostate Cancer Cohort
NCT00011349 ·Status: COMPLETED
-
From PSA to Stockholm3: Study Part 1
NCT03381105 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
NCT00977457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness
NCT05232578 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
NCT02070575 ·Status: COMPLETED
-
Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
NCT06600698 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Molecular Mechanisms Underlying Prostate Cancer Disparities
NCT02229565 ·Status: COMPLETED